Skip to main content
SpringerLink
Log in
Book cover

Staphylococcus aureus Infection and Disease pp 49–66Cite as

Capsule and Vaccine Development

  • Chapter

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R. H. Gorrill. The establishment of staphylococcal abscesses in the mouse kidney. Br J Exp Pathol 39: 203 (1958).

    PubMed Central  CAS  PubMed  Google Scholar 

  2. T. M. Donnelly, and D. M. Stark. Susceptibility of laboratory rats, hamsters, and mice to wound infection with Staphylococcus aureus. Am J Vet Res. 46: 2634 (1985).

    CAS  PubMed  Google Scholar 

  3. G. Singh, R. R. Marples, and A. M. Kligman. Experimental Staphylococcus aureus infections in humans. J Invest Dermatol 57: 149 (1971).

    Article  CAS  PubMed  Google Scholar 

  4. J. J. Hoogeterp, H. Mattie, A. M. Krul, and R. van Furth. The efficacy of rifampicin against Staphylococcus aureus in vitro and in an experimental infection in normal and granulocytopenic mice. Scand J Infect Dis. 20: 649 (1988).

    Article  CAS  PubMed  Google Scholar 

  5. S. R. Sharar, R. K. Winn, C. E. Murry, J. M. Harlan, and C. L. Rice. A CD 18 monoclonal antibody increases the incidence and severity of subcutaneous abscess formation after highdose Staphylococcus aureus injection in rabbits. Surgery. 110: 213 (1991).

    CAS  PubMed  Google Scholar 

  6. E D. Lowy. Medical progress: Staphylococcus aureus infections. N Engl Med. 339: 520 (1998).

    Article  CAS  Google Scholar 

  7. G. L. Archer. Staphylococcus aureus: A well-armed pathogen. Clin Infect Dis. 26: 1179 (1998).

    Article  CAS  PubMed  Google Scholar 

  8. J. B. Robbins, S. R, W. B. Egan, W. Vann, and D. Liu. Virulence properties of bacterial capsular polysaccharides-unanswered questions, in The Molecular Basis of Microbial Pathogenicity. H. Smith, J. Skehel, M. Turner, eds. Verlag Chemie GmbH, Weinheim, (1980).

    Google Scholar 

  9. D. Sompolinsky, Z. Samra, W. W. Karakawa, W. E Vann, R. Schneerson, and Z. Malik. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J Clin Microbiol. 22: 828 (1985).

    PubMed Central  CAS  PubMed  Google Scholar 

  10. H. K. Hochkeppel, D. G. Braun, W. Vischer, A. Imm, S. Sutter, U. Staeubli, and R. Guggenheim. Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8. J Clin Microbiol. 25: 526 (1987).

    PubMed Central  CAS  PubMed  Google Scholar 

  11. W. W. Karakawa, and W. F. Vann. Capsular polysaccharides of Staphylococcus aureus. Semin Infect Dis. 4: 285 (1982).

    CAS  Google Scholar 

  12. R. D. Arbeit, W. W. Karakawa, W. F. Vann, and J. B. Robbins. Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis. 2: 85 (1984).

    Article  CAS  PubMed  Google Scholar 

  13. W. W. Karakawa, A. Sutton, R. Schneerson, A. Karpas, and W. F. Vann. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun. 56: 1090 (1988).

    PubMed Central  CAS  PubMed  Google Scholar 

  14. P. Peterson, B. Wilkinson, Y Kim, Schmeling, and P. Quie. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun. 19: 943 (1978).

    PubMed Central  CAS  PubMed  Google Scholar 

  15. M. Thakker, J.-S. Park, V. Carey, and J. C. Lee. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect Immun. 66: 5183 (1998).

    PubMed Central  CAS  PubMed  Google Scholar 

  16. M. Melly, L. Duke, D.-F. Liau, and J. Hash. Biological properties of the encapsulated Staphylococcus aureus M. Infect Immun. 10: 389 (1974).

    PubMed Central  CAS  PubMed  Google Scholar 

  17. B. J. Wilkinson, P. K. Peterson, and P. G. Quie. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun. 23: 502 (1979).

    PubMed Central  CAS  PubMed  Google Scholar 

  18. S. Xu, R. D. Arbeit, and J. C. Lee. Phagocytic killing of encapsulated and microendcapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun. 60: 1358 (1992).

    PubMed Central  CAS  PubMed  Google Scholar 

  19. J. C. Lee, E Michon, N. E. Perez, C. A. Hopkins, and G. B. Pier. Chemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus. Infect Immun. 55: 2191 (1987).

    PubMed Central  CAS  PubMed  Google Scholar 

  20. B. J. Wilkinson, S. P. Sisson, Y Kim, and P. K. Peterson. Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. InfectImmun. 26: 1159 (1979).

    CAS  Google Scholar 

  21. A. Albus, R. D. Arbeit, and J. C. Lee. Virulence of Staphylococcus aureus mutants altered in type 5 capsuleproduction. Infect Immun. 59: 1008 (1991).

    PubMed Central  CAS  PubMed  Google Scholar 

  22. N. Bhasin, A. Albus, F. Michon, P. J. Livolsi, J.4. Park, and J. C. Lee. Identification of a gene essential for O-acetylation of the Staphylococcus aureus type 5 capsular polysaccharide. Mol Microbiol. 27: 9 (1998).

    Article  CAS  PubMed  Google Scholar 

  23. A.I. Fattom, J. Sarwar, L. Basham, S. Ennifar, and R. Naso. Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines. InfectImmun. 66: 4588 (1998).

    CAS  Google Scholar 

  24. J. C. Lee, J.-S. Park, S. E. Shepherd, V. Carey, and A. Fattom. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun. 65: 4146 (1997).

    PubMed Central  CAS  PubMed  Google Scholar 

  25. M. Propst, S. Stewart, J. C. Lee, S. Fuller, and G. S. Bixler. Opsonophagocytosis of Staphylococcus aureus type 5: involvement of the O-acetyl moiety on the capsular polysac-charide, in: Abstract of the 98th General Meeting of the American Society for Microbiology: E-–47 (1998).

    Google Scholar 

  26. R. D. Ekstedt. Studies on immunity to staphylococcal infection in mice. II. Effect of immunization with fractions of Staphylococcus aureus prepared by physical and chemical methods. J Infect Dis. 112: 152 (1963).

    Article  Google Scholar 

  27. R. Ekstedt. Studies on immunity to staphylococcal infection in mice. I. Effectof dosage, viability, and interval between immunization and challenge on resistance to infection following injectionof whole cell vaccines. J Infect Dis. 112: 143 (1963).

    Article  CAS  Google Scholar 

  28. S. Fisher. A heat stable protective staphylococcal antigen. Aust J Exp Biol. 38: 479 (1960).

    Article  CAS  Google Scholar 

  29. M. Fisher, H. Devlin, and A. Erlandson. A new staphylococcal antigen. Its preparation and immunizing activity against experimental infections. Nature. 199: 1074 (1963).

    Article  CAS  PubMed  Google Scholar 

  30. R. Ekstedt. Studies on immunity to staphylococcal infection in mice. The role of IV specific and nonspecific immunity. J Infect Dis. 116: 514 (1966).

    Article  CAS  PubMed  Google Scholar 

  31. J. C. Lee, N. E. Perez, C. A. Hopkins, and G. B. Pier. Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection. J Infect Dis. 157: 723 (1988).

    Article  CAS  PubMed  Google Scholar 

  32. B. J. Wilkinson. Staphylococcal capsules and slime, in: Staphylococci and Staphylococcal Infections. C. Easmon, C. Adlam, eds. Vol 2. Academic Press, London, 1983.

    Google Scholar 

  33. I.-M. Nilsson, J. C. Lee, T. Bremell, C. Ryden, and A. Tarkowski. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun. 65: 4216 (1997).

    PubMed Central  CAS  PubMed  Google Scholar 

  34. L. M. Baddour, C. Lowrance, A. Albus, J. H. Lowrance, S. K. Anderson, and J. C. Lee. Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. J Infect Dis. 165: 749 (1992).

    Article  CAS  PubMed  Google Scholar 

  35. B. Christensson, A. Boutonnier, U. Rydiing, and J. M. Fournier. Diagnosing Staphylococcus aureus endocarditis by detecting antibodies against S. aureus capsular polysaccharide type 5 and 8. J Infect Dis. 163: 530 (1991).

    Article  CAS  PubMed  Google Scholar 

  36. A. Albus, J. M. Fournier, C. Wolz, A. Boutonnier, M. Ranke, N. Hoiby, and H. Hochkeppel. Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis. J Clin Microbiol 26: 2505 (1988).

    PubMed Central  CAS  PubMed  Google Scholar 

  37. A. Fattom, S. R., D. C. Watson, W. W. Karakawa, D. Fitzgerald, I. Pastan, and X. Li. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect Immun. 61: 1023 (1993).

    PubMed Central  CAS  PubMed  Google Scholar 

  38. H. Verbrugh, R. Peters, M. Rozenberg-Arska, P. Peterson, and J. Verhoef. Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections. J Infect Dis. 144: 1 (1981).

    Article  CAS  PubMed  Google Scholar 

  39. H. I. Wergeland, L. R. Haaheim, O. B. Natas, F. Wesenberg, and P. Oeding. Antibodies tostaphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patientswith staphylococcal infections. J Clin Microbiol 27: 1286 (1989).

    PubMed Central  CAS  PubMed  Google Scholar 

  40. P. G. Welch, A. Fattom, J. Moore, R. Schneerson, J. Shiloach, D. A. Bryla, and X. R. Li. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein a conjugate vaccine in patients on hemodialysis. J Amer Soc Nephrol. 7: 247 (1996).

    CAS  Google Scholar 

  41. J. Nemeth, and J. C. Lee. Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis. Infect Immun. 63: 375 (1995).

    PubMed Central  CAS  PubMed  Google Scholar 

  42. D. P. Greenberg, J. I. Ward, and A. S. Bayer. Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits. Infect Immun. 55: 3030 (1987).

    PubMed Central  CAS  PubMed  Google Scholar 

  43. A. Fattom, R. Schneerson, S. C. Szu, W. F. Vann, J. Shiloach, W. W. Karakawa, and J. B. Robbins. Synthesis and immunologic properties in mice ofvaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect Immun. 58: 2367 (1990).

    PubMed Central  CAS  PubMed  Google Scholar 

  44. F. B. Gilbert, B. Poutrel, and L. Sutra. Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide-ovalbumin conjugate. Vaccine. 12: 369 (1994).

    Article  CAS  PubMed  Google Scholar 

  45. L. Reynaud-Rondier, A. Voiland, and G. Michel. Conjugation of capsular polysaccharide to a-hemolysin from Staphylococcus aureus as a glycoprotein antigen. FEMS Microbiol Lett. 76: 193 (1991).

    Google Scholar 

  46. A. Fattom, X. Li, Y. H. Cho, A. Burns, A. Hawwari, S. E. Shepherd, and R. Coughlin. Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides. Vaccine. 13: 1288 (1995).

    Article  CAS  PubMed  Google Scholar 

  47. A. I. Fattom, J. Sarwar, A. Ortiz, and R. Naso. A Staphylococcus aureus capsular polysaccharide (CP) vaccineand CP-specific antibodies protect mice against bacterial challenge. InjectImmun. 64 1659 (1996).

    CAS  Google Scholar 

  48. A. S. Bayer, M. Ing, E. Kim, M. R. Yeaman, S. Shepherd, R. Naso, and A. Fattom. Role of anticapsular IgG in modifying the course of experimental Staphylococcus aureus endocarditis, in Abstracts of the 36th International Conference on Antimimbial Agents and Chemotherapy. American Society for Microbiology, G096 (1996).

    Google Scholar 

  49. K. B. Kiser, J. M. Cantey-Kiser, and J. C. Lee. Development and characterization of a Staphylococcus aureus nasalcolonization model in mice. Infect Immun. 67: 5001 (1999).

    PubMed Central  CAS  PubMed  Google Scholar 

  50. R. Naso, and A. Fattom. Polysaccharide conjugate vaccines for the prevention of grampositive bacterial infections. Adv Exp Med Biol. 397: 133 (1996).

    Article  CAS  PubMed  Google Scholar 

  51. D. McKenney, K. L. Pouliot, Y. Wang, V. Murthy, M. Ulrich, G. Doring, J. C. Lee, D. A. Goldmann, and G. B. Pier. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 284: 1523 (1999).

    Article  CAS  PubMed  Google Scholar 

  52. D. McKenney, J. Hubner, E. Muller, Y. Wang, D. A. Goldmann, and G. B. Pier. The ica locus of Staphylococcus epidermisdis encodes production of the capsular polysaccharide/ adhesin. Infect Immun. 66: 4711 (1998).

    PubMed Central  CAS  PubMed  Google Scholar 

  53. S. E. Cramton, C. Gerke, N. F. Schnell, W. W. Nichols, and E Gotz. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun. 67: 5427 (1999).

    PubMed Central  CAS  PubMed  Google Scholar 

  54. S. Takeda, G. B. Pier, Y. Kojima, M. Tojo, E. Muller, T. Tosteson, and D. A. Goldmann. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation. 84: 2539 (1991).

    Article  CAS  PubMed  Google Scholar 

  55. Y. Kojima, M. Tojo, D. A. Goldmann, T. D. Tosteson, and G. B. Pier. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter related bacteremia due to coagulase-negative staphylococci. J Infect Dis. 162: 435 (1990).

    Article  CAS  PubMed  Google Scholar 

  56. D. L. Watson, and C. G. Lee. Immunity to experimental staphylococcal mastitis comparison of live and killed vaccines. Aust Vet J. 54: 374 (1978).

    Article  CAS  PubMed  Google Scholar 

  57. D. L. Watson. Virulence of Staphylococcus aureus grown in vitro or in vivo. Res Vet Sci. 32: 311 (1982).

    CAS  PubMed  Google Scholar 

  58. D. L. Watson. Vaccination against experimental staphylococcal mastitis in ewes. Res Wt Sci. 45: 16 (1988).

    CAS  Google Scholar 

  59. D. L. Watson. Ovine opsonins for Staphylococcus aureus cell wall and pseudocapsule. Res Vet Sai 46: 89 (1989).

    Google Scholar 

  60. D. L. Watson, and C. L. Schwartzkoff. A field trial to test the efficacy of a staphylococcal mastitis vaccine in commercial dairies in Australia. Proc International Symp on Bovine Mastitis. Indianapolis, 73 (1990).

    Google Scholar 

  61. S. C. Nickerson, W. E. Owens, and R. L. Boddie. Effect of a Staphylococcus aureus bacterin on serum antibody, new infection, and mammary histology in nonlactating dairy cows. J Dairy Sci. 76: 1290 (1993).

    Article  CAS  PubMed  Google Scholar 

  62. D. L. Watson. Expression of a pseudocapsule by Staphylococcus aureus: influence of cultural conditions and relevance to mastitis. Res Vet Sci. 47: 152 (1989).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Channing Laboratory, Boston, MA, 02115

    Jean C. Lee

Authors
  1. Jean C. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida College of Medicine, Tampa, Florida

    Allen L. Honeyman  & Herman Friedman  & 

  2. University of Pisa, Pisa, Italy

    Mauro Bendinelli

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Kluwer Academic Publishers

About this chapter

Cite this chapter

Lee, J.C. (2001). Capsule and Vaccine Development. In: Honeyman, A.L., Friedman, H., Bendinelli, M. (eds) Staphylococcus aureus Infection and Disease. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46848-4_4

Download citation

  • DOI: https://doi.org/10.1007/0-306-46848-4_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46591-8

  • Online ISBN: 978-0-306-46848-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation